Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Illumina Inc
(NQ:
ILMN
)
113.70
-1.02 (-0.89%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Illumina Inc
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
'Halftime Report' Final Trades From Oct. 25: Illumina, JPMorgan, And More
October 26, 2021
On CNBC’s "Halftime Report" f...
Via
Benzinga
Bet On Biopharma: Data, Digitization, Discovery
October 16, 2021
The after-effects of pandemic-era policies will be with us for some time — with many supply chains still experiencing significant disruption. The worst of this “scarring” will heal. But the...
Via
Talk Markets
Illumina Insider Sold $1.2M In Company Stock
October 15, 2021
Alexander Aravanis, SVP And Chief Technology Officer at Illumina (NASDAQ:ILMN), made a large insider sell on October 12, according to a new SEC filing. What Happened: A Form 4...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Why Shares of Ilumina Slumped 11.3% in September
October 06, 2021
The company's merger with GRAIL concerned investors.
Via
The Motley Fool
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
September 28, 2021
Some trends will persist for decades.
Via
The Motley Fool
Illumina slides after 'Confusing' close of Grail deal amid antitrust probe
August 19, 2021
Citi sees some risk that Illumina's tactic does not sit well with the regulatory bodies.
Via
Talk Markets
UK's NHS Launches World's Largest Trial Of Blood Test For 50 Types
September 13, 2021
Britain's National Health Service (NHS) will begin the world's largest trial of Grail Inc's flagship Galleri blood test that can be used to detect...
Via
Benzinga
Illumina, Merck Join Hands For Homologous Recombination Deficiency CDx, Research Assay
September 07, 2021
Illumina Inc (NASDAQ: ILMN) and Merck & Co Inc (NYSE: MRK) provided more details on their partnership to develop and commercialize tests that gauge...
Via
Benzinga
Why Illumina Wants Grail Back So Badly
September 04, 2021
The gene-sequencing giant sees a huge opportunity in diagnostics.
Via
The Motley Fool
Forget About the Genomic Revolution, the Proteomic Revolution Is Coming
September 03, 2021
Thanks to one small protein sequencing startup, we're entering a new era of proteomics via NGPS technologies that will enable massively parallel protein sequencing.
Via
InvestorPlace
Workday And Lam Research Lead The QQQ
August 27, 2021
U.S. indices were trading higher Friday as investors eye Fed Chairman Powell's speech at the Jackson Hole Symposium and gauge Fed tapering policy. The Invesco QQQ Trust...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Looking into Illumina's Return on Capital Employed
August 24, 2021
Pulled from Benzinga Pro data Illumina (NASDAQ:ILMN) showed a loss in earnings since Q1, totaling $187.00 million. Sales, on the other hand, increased by 3.02% to $1.13 billion...
Via
Benzinga
Friday Fears and Other Stock News Updates
August 23, 2021
Toyota has cut its output 40% over fear of the Delta variant of Covid, plus shortages of electronics. This is terrifying markets outside the USA. And other global stock news updates.
Via
Talk Markets
58 Biggest Movers From Yesterday
August 20, 2021
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares climbed 63.7% to close at $1.22 on Thursday after dropping 12% on Wednesday. Sonnet BioTherapeutics recently...
Via
Benzinga
Microsoft And Cisco Gain As The QQQ Bounces Back Thursday
August 19, 2021
U.S. indices bounced back Thursday after falling Wednesday amid macro uncertainty due to COVID-19 delta variant concerns. The Invesco QQQ Trust Series 1 (NASDAQ: QQQ) gained...
Via
Benzinga
Exposures
COVID-19
Why Illumina Stock Just Dropped 10%
August 19, 2021
The genetic-testing company just blatantly defied its regulators.
Via
The Motley Fool
38 Stocks Moving In Thursday's Mid-Day Session
August 19, 2021
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares jumped 141% to $1.7950 after dropping 12% on Wednesday. Sonnet BioTherapeutics recently reported its financial...
Via
Benzinga
Illumina Stock Nosedives After DNA Giant Makes A 'Maverick Move' In Its Grail Takeover
August 19, 2021
Illumina stock tumbled Thursday after the company finished its $8 billion acquisition of Grail despite an ongoing investigation in Europe.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2021
August 19, 2021
Upgrades According to DA Davidson, the prior rating for PaySign Inc (NASDAQ:
Via
Benzinga
Illumina Completes Grail Buyout Despite Uncertainty In Regulatory Process
August 19, 2021
In defiance of FTC and EU scrutiny, Illumina Inc (NASDAQ: ILMN) went ahead to complete its $8 billion acquisition of Grail. The finalization of the buyout...
Via
Benzinga
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
August 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Providence Molecular Genomics Lab Utilizes Illumina Technology to Offer Genomics for All
August 18, 2021
Providence Molecular Genomics Lab Utilizes Illumina Technology to Offer Genomics for All
Via
News Direct
Topics
Product Recall
Exposures
Legal
Product Safety
Illumina Stock Earns Membership In Elite Club
August 17, 2021
Illumina saw its IBD SmartSelect Composite Rating rise to 97 Tuesday, up from 93 the day before.
Via
Investor's Business Daily
Illumina Coordinates Research and Efforts in China’s Rare Disease Community
August 16, 2021
Illumina Coordinates Research and Efforts in China’s Rare Disease Community
Via
News Direct
Illumina Delivers a Beat and a Raise in Q2
August 14, 2021
According to CEO Francis deSouza, the genetic life-sciences company is "firing on all cylinders."
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
EU Regulators Temporarily Pause Illumina, Grail Deal Investigation
August 12, 2021
The European Commission has temporarily suspended the provisional deadline for its investigation into Illumina Inc's (NASDAQ: ILMN) plans to buy Grail Inc,...
Via
Benzinga
Extending COVID Surveillance Capabilities Beyond Big Cities
August 11, 2021
With the debut of Illumina's COVIDSeq Assay, smaller labs are participating in Covid-19 surveillance
Via
News Direct
Exposures
COVID-19
Forget Robinhood, These 3 Healthcare Stocks Are Better Buys
August 11, 2021
Wait for pitches that are easy to hit before taking a swing.
Via
The Motley Fool
What Does the Future Look Like for Illumina Stock?
August 11, 2021
The leader in the genomics space is being treated like a monopoly, and is now running into federal regulation and oversight.
Via
The Motley Fool
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.